{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:21:26Z","timestamp":1794856886630,"version":"4.9.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2019R1A6A3A01093804"],"award-info":[{"award-number":["NRF-2019R1A6A3A01093804"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The pathogenesis of atopic dermatitis (AD) involves complex factors, including gut microbiota and immune modulation, which remain poorly understood. The aim of this study was to restore gut microbiota via fecal microbiota transplantation (FMT) to ameliorate AD in mice. FMT was performed using stool from donor mice. The gut microbiota was characterized via 16S rRNA sequencing and analyzed using Quantitative Insights into Microbial Ecology 2 with the DADA2 plugin. Gut metabolite levels were determined by measuring fecal short-chain fatty acid (SCFA) contents. AD-induced allergic responses were evaluated by analyzing blood parameters (IgE levels and eosinophil percentage, eosinophil count, basophil percentage, and monocyte percentage), the levels of Th1 and Th2 cytokines, dermatitis score, and the number of mast cells in the ileum and skin tissues. Calprotectin level was measured to assess gut inflammation after FMT. FMT resulted in the restoration of gut microbiota to the donor state and increases in the levels of SCFAs as gut metabolites. In addition, FMT restored the Th1\/Th2 balance, modulated Tregs through gut microbiota, and reduced IgE levels and the numbers of mast cells, eosinophils, and basophils. FMT is associated with restoration of gut microbiota and immunologic balance (Th1\/Th2) along with suppression of AD-induced allergic responses and is thus a potential new therapy for AD.<\/jats:p>","DOI":"10.1038\/s12276-021-00627-6","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T06:03:08Z","timestamp":1621490588000},"page":"907-916","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":126,"title":["Gut microbiota restoration through fecal microbiota transplantation: a new atopic dermatitis therapy"],"prefix":"10.1038","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3343-4820","authenticated-orcid":false,"given":"Jong-Hwa","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7680-5214","authenticated-orcid":false,"given":"Kiyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9649-3919","authenticated-orcid":false,"given":"Wonyong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"key":"627_CR1","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.clindermatol.2017.03.010","volume":"35","author":"J Udkoff","year":"2017","unstructured":"Udkoff, J., Waldman, A., Ahluwalia, J., Borok, J. & Eichenfield, L. F. Current and emerging topical therapies for atopic dermatitis. Clin. Dermatol. 35, 375\u2013382 (2017).","journal-title":"Clin. Dermatol."},{"key":"627_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.anai.2017.09.055","volume":"120","author":"PM Brunner","year":"2018","unstructured":"Brunner, P. M., Leung, D. Y. M. & Guttman-Yassky, E. Immunologic, microbial, and epithelial interactions in atopic dermatitis. Ann. Allergy Asthma Immunol. 120, 34\u201341 (2018).","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"627_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/CCID.S130013","volume":"10","author":"U Wollina","year":"2017","unstructured":"Wollina, U. Microbiome in atopic dermatitis. Clin. Cosmet. Investig. Dermatol. 10, 51\u201356 (2017).","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"627_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/vms3.24","volume":"2","author":"JM Craig","year":"2016","unstructured":"Craig, J. M. Atopic dermatitis and the intestinal microbiota in humans and dogs. Vet. Med. Sci. 2, 95\u2013105 (2016).","journal-title":"Vet. Med. Sci."},{"key":"627_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/MCO.0000000000000044","volume":"17","author":"CE West","year":"2014","unstructured":"West, C. E. Gut microbiota and allergic disease: new findings. Curr. Opin. Clin. Nutr. Metab. Care 17, 261\u2013266 (2014).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"627_CR6","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.biotechadv.2016.08.003","volume":"34","author":"D Li","year":"2016","unstructured":"Li, D., Wang, P., Wang, P., Hu, X. & Chen, F. The gut microbiota: a treasure for human health. Biotechnol. Adv. 34, 1210\u20131224 (2016).","journal-title":"Biotechnol. Adv."},{"key":"627_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11739-014-1069-4","volume":"9","author":"G Cammarota","year":"2014","unstructured":"Cammarota, G., Ianiro, G., Bibbo, S. & Gasbarrini, A. Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation? Intern. Emerg. Med. 9, 365\u2013373 (2014).","journal-title":"Intern. Emerg. Med."},{"key":"627_CR8","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.coph.2009.06.016","volume":"9","author":"PD Cani","year":"2009","unstructured":"Cani, P. D. & Delzenne, N. M. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr. Opin. Pharmacol. 9, 737\u2013743 (2009).","journal-title":"Curr. Opin. Pharmacol."},{"key":"627_CR9","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1038\/cti.2016.29","volume":"5","author":"JL Richards","year":"2016","unstructured":"Richards, J. L., Yap, Y. A., McLeod, K. H., Mackay, C. R. & Marino, E. Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseases. Clin. Transl. Immunol. 5, e82 (2016).","journal-title":"Clin. Transl. Immunol."},{"key":"627_CR10","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson, T. R. et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167, 1469\u20131480 e1412 (2016).","journal-title":"Cell"},{"key":"627_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3389\/fmicb.2016.00507","volume":"7","author":"IA Rather","year":"2016","unstructured":"Rather, I. A. et al. Probiotics and atopic dermatitis: an overview. Front. Microbiol. 7, 507 (2016).","journal-title":"Front. Microbiol."},{"key":"627_CR12","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jaci.2011.10.025","volume":"129","author":"TR Abrahamsson","year":"2012","unstructured":"Abrahamsson, T. R. et al. Low diversity of the gut microbiota in infants with atopic eczema. J. Allergy Clin. Immunol. 129, 434\u2013440 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"627_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12275-015-4483-z","volume":"53","author":"H Kim","year":"2015","unstructured":"Kim, H. et al. Oral administration of Lactobacillus plantarum lysates attenuates the development of atopic dermatitis lesions in mouse models. J. Microbiol. 53, 47\u201352 (2015).","journal-title":"J. Microbiol."},{"key":"627_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrgastro.2011.244","volume":"9","author":"TJ Borody","year":"2011","unstructured":"Borody, T. J. & Khoruts, A. Fecal microbiota transplantation and emerging applications. Nat. Rev. Gastroenterol. Hepatol. 9, 88\u201396 (2011).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"627_CR15","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/MCG.0b013e3181e5d06b","volume":"44","author":"MJ Grehan","year":"2010","unstructured":"Grehan, M. J. et al. Durable alteration of the colonic microbiota by the administration of donor fecal flora. J. Clin. Gastroenterol. 44, 551\u2013561 (2010).","journal-title":"J. Clin. Gastroenterol."},{"key":"627_CR16","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1128\/AEM.66.6.2578-2588.2000","volume":"66","author":"GW Tannock","year":"2000","unstructured":"Tannock, G. W. et al. Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl. Environ. Microbiol. 66, 2578\u20132588 (2000).","journal-title":"Appl. Environ. Microbiol."},{"key":"627_CR17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1365-2036.2012.05220.x","volume":"36","author":"JL Anderson","year":"2012","unstructured":"Anderson, J. L., Edney, R. J. & Whelan, K. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment. Pharmacol. Ther. 36, 503\u2013516 (2012).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"627_CR18","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1001\/jama.2014.13875","volume":"312","author":"I Youngster","year":"2014","unstructured":"Youngster, I. et al. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA 312, 1772\u20131778 (2014).","journal-title":"JAMA"},{"key":"627_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01751-y","volume":"7","author":"D Zhou","year":"2017","unstructured":"Zhou, D. et al. Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota. Sci. Rep. 7, 1529 (2017).","journal-title":"Sci. Rep."},{"key":"627_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-36864-5","volume":"9","author":"JH Kim","year":"2019","unstructured":"Kim, J. H., Kim, K. & Kim, W. Cream cheese-derived Lactococcus chungangensis CAU 28 modulates the gut microbiota and alleviates atopic dermatitis in BALB\/c mice. Sci. Rep. 9, 446 (2019).","journal-title":"Sci. Rep."},{"key":"627_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.12688\/f1000research.2-177.v1","volume":"2","author":"T Myers-Morales","year":"2013","unstructured":"Myers-Morales, T., Bussell, K. M. & D\u2019Orazio, S. E. Fecal transplantation does not transfer either susceptibility or resistance to food borne listeriosis in C57BL\/6 and BALB\/c\/By mice. F1000Res 2, 177 (2013).","journal-title":"F1000Res"},{"key":"627_CR22","first-page":"692","volume":"6","author":"M Li","year":"2015","unstructured":"Li, M. et al. Fecal microbiota transplantation and bacterial consortium transplantation have comparable effects on the re-establishment of mucosal barrier function in mice with intestinal dysbiosis. Front. Microbiol. 6, 692 (2015).","journal-title":"Front. Microbiol."},{"key":"627_CR23","first-page":"e27295v27292","volume":"6","author":"E Bolyen","year":"2018","unstructured":"Bolyen, E. et al. QIIME 2: reproducible, interactive, scalable, and extensible microbiome data science. PeerJ Prepr. 6, e27295v27292 (2018).","journal-title":"PeerJ Prepr."},{"key":"627_CR24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581\u2013583 (2016).","journal-title":"Nat. Methods"},{"key":"627_CR25","first-page":"7","volume":"3","author":"J Oksanen","year":"2015","unstructured":"Oksanen, J. et al. Vegan: community ecology package. R package vegan, vers. 2.2-1. World Agrofor. 3, 7\u201381 (2015).","journal-title":"World Agrofor."},{"key":"627_CR26","doi-asserted-by":"publisher","first-page":"e61217","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie, P. J. & Holmes, S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE 8, e61217 (2013).","journal-title":"PLoS ONE"},{"key":"627_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fmicb.2016.00455","volume":"7","author":"A Mosca","year":"2016","unstructured":"Mosca, A., Leclerc, M. & Hugot, J. P. Gut microbiota diversity and human diseases: should we reintroduce key predators in our ecosystem? Front. Microbiol. 7, 455 (2016).","journal-title":"Front. Microbiol."},{"key":"627_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/ajd.12435","volume":"58","author":"CL Thomas","year":"2017","unstructured":"Thomas, C. L. & Fernandez-Penas, P. The microbiome and atopic eczema: more than skin deep. Australas. J. Dermatol. 58, 18\u201324 (2017).","journal-title":"Australas. J. Dermatol."},{"key":"627_CR29","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1136\/archdischild-2013-305799","volume":"99","author":"SJ Allen","year":"2014","unstructured":"Allen, S. J. et al. Probiotics in the prevention of eczema: a randomised controlled trial. Arch. Dis. Child. 99, 1014\u20131019 (2014).","journal-title":"Arch. Dis. Child."},{"issue":"Suppl 1","key":"627_CR30","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1097\/MCG.0000000000000233","volume":"48","author":"AA Niccoli","year":"2014","unstructured":"Niccoli, A. A. et al. Preliminary results on clinical effects of probiotic Lactobacillus salivarius LS01 in children affected by atopic dermatitis. J. Clin. Gastroenterol. 48(Suppl 1), S34\u2013S36 (2014).","journal-title":"J. Clin. Gastroenterol."},{"key":"627_CR31","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3748\/wjg.v21.i1.102","volume":"21","author":"MQ Xu","year":"2015","unstructured":"Xu, M. Q. et al. Fecal microbiota transplantation broadening its application beyond intestinal disorders. World J. Gastroenterol. 21, 102\u2013111 (2015).","journal-title":"World J. Gastroenterol."},{"key":"627_CR32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12275-018-8037-z","volume":"56","author":"JA Cho","year":"2018","unstructured":"Cho, J. A. & Chinnapen, D. J. F. Targeting friend and foe: emerging therapeutics in the age of gut microbiome and disease. J. Microbiol. 56, 183\u2013188 (2018).","journal-title":"J. Microbiol."},{"key":"627_CR33","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/femsre\/fuw046","volume":"41","author":"D Rojo","year":"2017","unstructured":"Rojo, D. et al. Exploring the human microbiome from multiple perspectives: factors altering its composition and function. FEMS Microbiol. Rev. 41, 453\u2013478 (2017).","journal-title":"FEMS Microbiol. Rev."},{"key":"627_CR34","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3389\/fimmu.2017.01036","volume":"8","author":"M Kespohl","year":"2017","unstructured":"Kespohl, M. et al. The microbial metabolite butyrate induces expression of Th1-associated factors in CD4(+) T cells. Front. Immunol. 8, 1036 (2017).","journal-title":"Front. Immunol."},{"key":"627_CR35","doi-asserted-by":"crossref","unstructured":"Liong, M.-T. Beneficial Microorganisms in Medical and Health Applications, Vol. 28 (Springer, 2015).","DOI":"10.1007\/978-3-319-23213-3"},{"key":"627_CR36","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3920\/BM2015.0056","volume":"6","author":"HK Kim","year":"2015","unstructured":"Kim, H. K. et al. Probiotic supplementation influences faecal short chain fatty acids in infants at high risk for eczema. Benef. Microbes 6, 783\u2013790 (2015).","journal-title":"Benef. Microbes"},{"key":"627_CR37","doi-asserted-by":"publisher","first-page":"575","DOI":"10.4168\/aair.2018.10.6.575","volume":"10","author":"G Sharma","year":"2018","unstructured":"Sharma, G. & Im, S. H. Probiotics as a potential immunomodulating pharmabiotics in allergic diseases: current status and future prospects. Allergy Asthma Immunol. Res. 10, 575\u2013590 (2018).","journal-title":"Allergy Asthma Immunol. Res."},{"key":"627_CR38","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1039\/C8FO01946K","volume":"10","author":"C Tang","year":"2019","unstructured":"Tang, C. et al. The impacts of natural polysaccharides on intestinal microbiota and immune responses\u2014a review. Food Funct. 10, 2290\u20132312 (2019).","journal-title":"Food Funct."},{"key":"627_CR39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nm.3444","volume":"20","author":"A Trompette","year":"2014","unstructured":"Trompette, A. et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 20, 159\u2013166 (2014).","journal-title":"Nat. Med."},{"key":"627_CR40","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/MCO.0b013e32833eebe5","volume":"13","author":"K Meijer","year":"2010","unstructured":"Meijer, K., de Vos, P. & Priebe, M. G. Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health? Curr. Opin. Clin. Nutr. Metab. Care 13, 715\u2013721 (2010).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"627_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.humic.2018.01.004","volume":"7","author":"M Million","year":"2018","unstructured":"Million, M. et al. New insights in gut microbiota and mucosal immunity of the small intestine. Hum. Microb. J. 7, 23\u201332 (2018).","journal-title":"Hum. Microb. J."},{"key":"627_CR42","first-page":"82","volume":"36","author":"SC Seo","year":"2018","unstructured":"Seo, S. C. et al. Elevated fecal calprotectin levels are associated with severity of atopic dermatitis in children. Asian Pac. J. Allergy Immunol. 36, 82\u201387 (2018).","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"627_CR43","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/exd.12563","volume":"23","author":"S Jin","year":"2014","unstructured":"Jin, S. et al. DAMP molecules S100A9 and S100A8 activated by IL-17A and house-dust mites are increased in atopic dermatitis. Exp. Dermatol. 23, 938\u2013941 (2014).","journal-title":"Exp. Dermatol."},{"key":"627_CR44","first-page":"5256","volume":"8","author":"J Liu","year":"2016","unstructured":"Liu, J. et al. Probiotics enhance the effect of allergy immunotherapy on regulating antigen specific B cell activity in asthma patients. Am. J. Transl. Res. 8, 5256\u20135270 (2016).","journal-title":"Am. J. Transl. Res."},{"key":"627_CR45","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1189\/jlb.1109753","volume":"89","author":"P Gourbeyre","year":"2011","unstructured":"Gourbeyre, P., Denery, S. & Bodinier, M. Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions. J. Leukoc. Biol. 89, 685\u2013695 (2011).","journal-title":"J. Leukoc. Biol."},{"key":"627_CR46","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jaci.2013.07.046","volume":"132","author":"MC Siracusa","year":"2013","unstructured":"Siracusa, M. C., Kim, B. S., Spergel, J. M. & Artis, D. Basophils and allergic inflammation. J. Allergy Clin. Immunol. 132, 789\u2013801 (2013).","journal-title":"J. Allergy Clin. Immunol."},{"key":"627_CR47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.alcohol.2004.01.004","volume":"32","author":"X Zhu","year":"2004","unstructured":"Zhu, X. et al. Chronic ethanol ingestion by mice increases expression of CD80 and CD86 by activated macrophages. Alcohol 32, 91\u2013100 (2004).","journal-title":"Alcohol"},{"key":"627_CR48","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.febslet.2005.12.093","volume":"580","author":"Lee","year":"2006","unstructured":"Lee et al. Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274). FEBS Lett. 580, 755\u2013762 (2006).","journal-title":"FEBS Lett."},{"key":"627_CR49","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00403-015-1588-5","volume":"307","author":"DS Kim","year":"2015","unstructured":"Kim, D. S. et al. Programmed death-ligand 1, 2 expressions are decreased in the psoriatic epidermis. Arch. Dermatol. Res. 307, 531\u2013538 (2015).","journal-title":"Arch. Dermatol. Res."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-021-00627-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-021-00627-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-021-00627-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T01:05:24Z","timestamp":1650243924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-021-00627-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["627"],"URL":"https:\/\/doi.org\/10.1038\/s12276-021-00627-6","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"21 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}